Protagonist Therapeutics PTGX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's free cash flow?
- Protagonist Therapeutics (PTGX) reported free cash flow of -$49.16M in Q1 2026.
- How has Protagonist Therapeutics's free cash flow changed year-over-year?
- Protagonist Therapeutics's free cash flow decreased by 139.4% year-over-year, from $124.82M to -$49.16M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.